Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature
- PMID: 18852220
- DOI: 10.1177/0961203308091539
Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature
Abstract
Systemic lupus erythematosus (SLE) often coexists with other diseases. Diabetes mellitus (DM) is an example and patients with overlap SLE-DM can present with clinical features common to both disorders. In this review, we describe the patients with overlap SLE-DM, focussing on the clinical features common to both diseases that these patients can present, and on the challenges of managing such complications. A detailed review of the patients' notes (n = 485) was performed. At every outpatient appointment the patients' urine was tested for glucose, protein and blood. Patients with persistent glycosuria were investigated with fasting blood glucose and a glucose tolerance test to help make the diagnosis of DM. Particular note was made of those patients whose symptoms could be due to SLE, DM or both. Nine patients with DM were identified. Three had type 1 DM, four had type 2 DM and two were considered to have steroid-induced DM. Among these patients, three had renal involvement (two with WHO class IV lupus nephritis); two had peripheral neuropathy (one had a mixed sensory and motor neuropathy, one had a sensory peripheral neuropathy); two patients had retinopathy and cataracts and one had angina. The combination of SLE and DM is uncommon but the predisposition to renal, peripheral neuropathy and retinal disease means that great care must be taken when deciding which clinical feature is due to which disease, because active SLE requires additional immunosuppression whereas DM requires optimization of the metabolic control. Interestingly, although in theory patients with SLE and DM are in double-jeopardy of developing atherosclerosis, to date, only one of our overlap patients has developed angina.
Similar articles
-
The outcome of renal transplantation among systemic lupus erythematosus patients.Nephrol Dial Transplant. 2007 Dec;22(12):3623-30. doi: 10.1093/ndt/gfm459. Epub 2007 Jul 19. Nephrol Dial Transplant. 2007. PMID: 17640941
-
Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature.Lupus. 2007;16(4):289-97. doi: 10.1177/0961203307078001. Lupus. 2007. PMID: 17439937 Review.
-
[Detection of soluble endothelial protein C receptor (sEPCR) in patients with CHD, DM and SLE].Zhonghua Xue Ye Xue Za Zhi. 2000 Sep;21(9):472-4. Zhonghua Xue Ye Xue Za Zhi. 2000. PMID: 11877022 Chinese.
-
Upper airway disease in systemic lupus erythematosus: a report of 4 cases and a review of the literature.J Rheumatol. 1992 Aug;19(8):1186-90. J Rheumatol. 1992. PMID: 1404152 Review.
-
[Comparative clinico-immunologic and microcirculation studies in families of patients with type 1 diabetes mellitus and systemic lupus erythematosus].Vestn Akad Med Nauk SSSR. 1989;(5):22-8. Vestn Akad Med Nauk SSSR. 1989. PMID: 2756777 Russian.
Cited by
-
Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus.JAMA Netw Open. 2024 Jun 3;7(6):e2416578. doi: 10.1001/jamanetworkopen.2024.16578. JAMA Netw Open. 2024. PMID: 38865122 Free PMC article.
-
A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.PLoS One. 2023 May 17;18(5):e0285915. doi: 10.1371/journal.pone.0285915. eCollection 2023. PLoS One. 2023. PMID: 37195987 Free PMC article.
-
Nephrotic syndrome in the course of type 1 diabetes mellitus and systemic lupus erythematosus with secondary antiphospholipid syndrome - diagnostic and therapeutic problems.Reumatologia. 2020;58(5):331-334. doi: 10.5114/reum.2020.100105. Epub 2020 Oct 20. Reumatologia. 2020. PMID: 33227048 Free PMC article. Review.
-
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.Mediators Inflamm. 2018 Feb 18;2018:3424136. doi: 10.1155/2018/3424136. eCollection 2018. Mediators Inflamm. 2018. PMID: 29670462 Free PMC article. Review.
-
Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus.Sci Rep. 2018 Apr 16;8(1):6008. doi: 10.1038/s41598-018-24529-2. Sci Rep. 2018. PMID: 29662119 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical